Jinwon Life Sciences has ranked among the top searched stocks for 14 days in the past month.


As of 2:30 PM on the 9th, Jinwon Life Sciences is trading at 25,050 KRW, down 4.21% from the previous day. This represents a 9.73% decrease compared to November 11. Jinwon Life Sciences is known as a company specializing in the development of gene therapies and gene vaccines.

Today, foreigners have tentatively been recorded as net buyers of 20,324 shares. Over the past five days, individual investors have net purchased 38,819 shares, while foreigners and institutions have net purchased 1,930 shares and net sold 1,441 shares, respectively.


On December 7, Jinwon Life Sciences was a market topic with the news of domestic clinical approval for the COVID-19 vaccine, described as a 'bullish trend.'


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing